A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father

Transfus Clin Biol. 2020 Nov;27(4):269-270. doi: 10.1016/j.tracli.2020.09.001. Epub 2020 Sep 25.

Authors

Glykeria Vlachogianni¹, Helen Hassapopoulou-Matamis², Constantina Politis³, Eirini Fylaki¹, Andreas Mentis⁴

Affiliations

¹ Intensive Care Unit, General Hospital Agios Dimitrios, Thessaloniki, Greece.
² Blood Centre of the AHEPA University General Hospital, Thessaloniki, Greece.
³ Coordinating Centre for Haemovigilance and Surveillance of Transfusion (SKAEM) of the Hellenic National Public Health Organization (NPHO), Agrafon 3-5, 15123 Attika, Greece. Electronic address: cpolitis11@yahoo.gr.
⁴ Public Health Laboratory, Hellenic Pasteur Institute, Athens, Greece.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Aged
Anti-Bacterial Agents / therapeutic use
Antifungal Agents / therapeutic use
Antiviral Agents / therapeutic use
COVID-19 / therapy*
COVID-19 Drug Treatment
COVID-19 Serotherapy
Cardiotonic Agents / therapeutic use
Combined Modality Therapy
Compassionate Use Trials
Directed Tissue Donation*
Drug Resistance, Multiple
Drug Substitution
Drug Therapy, Combination
Fatal Outcome
Greece
Humans
Hydroxychloroquine / therapeutic use
Immunization, Passive
Lopinavir / therapeutic use
Male
Respiration, Artificial
Ritonavir / therapeutic use
Shock, Septic / etiology
Superinfection
Time-to-Treatment

Substances

Adrenal Cortex Hormones
Anti-Bacterial Agents
Antifungal Agents
Antiviral Agents
Cardiotonic Agents
Lopinavir
Hydroxychloroquine
Ritonavir